Joseph Tintelnot

10PUBLICATIONS
68CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 19, 2026
Differential effects of prior versus concomitant Steroid and Antibiotic Treatment on Immunotherapy Efficacy - A Pooled Analysis of the RAMONA, INTEGA, OPTIM, ELDORANDO, FORCE, TITAN-RCC and TITAN-TCC Trials of the German AIO Study Group.

|Oct 18, 2025
Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial.

Alexander Stein, Eray Goekkurt, Salah-Eddin Al-Batran

|Nov 11, 2024
Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy.

Joseph Tintelnot, Lisa Paschold, Eray Goekkurt

|Mar 13, 2024
Tumor Response Evaluation Using iRECIST: Feasibility and Reliability of Manual Versus Software-Assisted Assessments.

Inka Ristow, Lennart Well, Nis Jesper Wiese

|Nov 23, 2023
Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial.

Hans-Joachim Schmoll, Julia Mann, Fabian Meinert

|Sep 20, 2023
Calcium channel β3 subunit regulates ATP-dependent migration of dendritic cells.

Marcel S Woo, Friederike Ufer, Jana K Sonner

Pageof 2

Frequent Collaborators

3 joint publications

Alexander Stein

3 joint publications

Martin Schönlein

2 joint publications

Cenap Güngör

2 joint publications

Leonie Konczalla